These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11376017)

  • 1. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
    Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
    J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
    Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
    Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stathmin immunoreactivity in phaeochromocytomas and paragangliomas: differential expression between benign and malignant neoplasms.
    Lin WC; Chen SC; Chuang YT; Kuo KL; Huang KH
    Asian J Surg; 2011 Jan; 34(1):15-22. PubMed ID: 21515208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas.
    Salmenkivi K; Heikkilä P; Haglund C; Louhimo J; Arola J
    Histopathology; 2003 Jul; 43(1):62-71. PubMed ID: 12823714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management.
    Foo SH; Chan SP; Ananda V; Rajasingam V
    Singapore Med J; 2010 May; 51(5):e89-93. PubMed ID: 20593136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
    Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
    J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
    Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
    Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Novel Mutations and Expressions of
    Islam F; Pillai S; Gopalan V; Lam AK
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
    Gupta D; Shidham V; Holden J; Layfield L
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years.
    Regezi JA; Dekker NP; McMillan A; Ramirez-Amador V; Meneses-Garcia A; Ruiz-Godoy Rivera LM; Chrysomali E; Ng IO
    Oral Oncol; 1999 Jul; 35(4):379-83. PubMed ID: 10645402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological features, Ki-67 and Bcl-2 immunohistochemical expression and their correlation with the aggressiveness of pheochromocytomas.
    Jovanovic R; Kostadinova-Kunovska S; Bogoeva B; Spasevska L; Petrusevska G
    Prilozi; 2012; 33(2):23-40. PubMed ID: 23425867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
    Kimura N; Takayanagi R; Takizawa N; Itagaki E; Katabami T; Kakoi N; Rakugi H; Ikeda Y; Tanabe A; Nigawara T; Ito S; Kimura I; Naruse M;
    Endocr Relat Cancer; 2014 Jun; 21(3):405-14. PubMed ID: 24521857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
    Emanuels AG; Koudstaal J; Burger MP; Hollema H
    Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.
    Skomedal H; Kristensen GB; Abeler VM; Børresen-Dale AL; Tropé C; Holm R
    J Pathol; 1997 Feb; 181(2):158-65. PubMed ID: 9120719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mdm2: a bridge over the two tumour suppressors, p53 and Rb.
    Yap DB; Hsieh JK; Chan FS; Lu X
    Oncogene; 1999 Dec; 18(53):7681-9. PubMed ID: 10618708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors.
    Eymin B; Gazzeri S; Brambilla C; Brambilla E
    Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
    Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of S-100 protein in sustentacular cells of phaeochromocytomas and paragangliomas.
    Schroder HD; Johannsen L
    Histopathology; 1986 Oct; 10(10):1023-33. PubMed ID: 3536711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
    Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.